Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with advanced epithelial ovarian cancer (including fallopian tube or peritoneal cancer) at Stage II, III, or IV, who are being considered for surgery either upfront or after an initial course of chemotherapy.
- People who are willing and able to give their signed agreement to participate in the study.
- Women aged 18 years or older.
Who may not be able to join:
- People whose other health conditions mean that major surgery would not be considered safe for them.
- People with a low performance or functioning score, meaning their general health and ability to carry out daily activities falls below a certain level (confirm with trial site).
- People who have had, or currently have, any other type of cancer, regardless of whether it has been treated.
- People with a past or recent history of pancreatitis (inflammation of the pancreas) or hepatitis (inflammation of the liver).
- People with a past or recent history of fluid around the lungs, lung damage, or serious breathing problems.
- People with significant heart conditions (confirm with trial site for specific details).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Roberto Tozzi, Professor, Azienda Ospedale Università di Padova
Phone: 0039-049-8213445
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety: rate of complications/morbidities; Efficacy: rate of complete resection (CR) in group 1; Feasibility: rate of procedures completed by laparoscopy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.